Notes 8, 9, 10, 11 and 12
8. Fixed Asset Investments
Investments at cost or written down value
| Cost |
Total
£m |
Investments
in other
shares
£m |
Loans
£m |
| At 1 January 2005 |
225.6 |
84.6 |
141.0 |
| Additions |
49.4 |
18.5 |
30.9 |
| Disposals |
(12.1) |
- |
(12.1) |
| At 31 December 2005 |
262.9 |
103.1 |
159.8 |
| Provision |
|
|
|
| At 1 January 2005 |
19.1 |
- |
19.1 |
| Increase in the year |
7.2 |
5.7 |
1.5 |
| At 31 December 2005 |
26.3 |
5.7 |
20.6 |
| Net book value |
|
|
|
| At 31 December 2005 |
236.6 |
97.4 |
139.2 |
| At 1 January 2005 |
206.5 |
84.6 |
121.9 |
The Company’s principal subsidiaries at 31 December 2005 are listed here.
9. Debtors
| |
2005
£m |
Restated
2004
£m |
| Amounts falling due within one year |
|
|
| Amounts owed by subsidiaries |
1.5 |
2.6 |
| Other debtors |
1.1 |
0.4 |
| Derivative financial instruments - forward exchange contracts |
1.1 |
0.3 |
| Derivative financial instruments - option exchange contracts |
0.1 |
1.2 |
| Tax recoverable |
0.3 |
0.1 |
| Prepayments and accrued income |
0.1 |
0.1 |
| |
4.2 |
4.7 |
10. Creditors
| |
2005
£m |
Restated
2004
£m |
| Amounts falling due within one year |
|
|
| Bank loans (unsecured) |
- |
24.7 |
| Amounts owed to subsidiaries |
151.0 |
119.1 |
| Derivative financial instruments - forward exchange contracts |
1.1 |
0.3 |
| Derivative financial instruments - option exchange contracts |
0.1 |
1.2 |
| Other creditors |
0.1 |
0.1 |
| Accruals and deferred income |
1.7 |
1.2 |
| |
154.0 |
146.6 |
| Amounts falling due after more than one year |
|
|
| Bank loans (unsecured) |
17.2 |
- |
| |
17.2 |
- |
11. Provisions for Liabilities and Charges
| |
Deferred
tax
£m |
| At 1 January 2005 and at 31 December 2005 |
0.1 |
| |
2005
£m |
2004
£m |
| Composition of deferred tax provision |
|
|
| Accelerated tax depreciation allowances |
0.1 |
0.1 |
| Other timing differences |
- |
- |
| |
0.1 |
0.1 |
The deferred tax provision arose because of timing differences between the treatment of certain items for tax and accounting purposes.
12. Share Capital
The authorised share capital at 31 December 2005 consisted of 65,000,000 (2004: 65,000,000) shares of 20p each, of which 41,086,719 were allotted and fully paid. The movement during the year was:
| |
Shares |
Issued
share
capital
£m |
| At 1 January 2005 |
41,081,105 |
8.2 |
| Exercise of share options |
5,614 |
- |
| At 31 December 2005 |
41,086,719 |
8.2 |
12a. Share-based Payments
Details of the share-based payments can be found here.
12b. Share Option Schemes
At 31 December 2005 the following options had been granted and remained outstanding under the Company’s share option schemes:
| |
Number
of shares |
Exercise
prices |
Dates
normally
exercisable |
| United Kingdom SAYE schemes |
270,962 |
231p-595p |
2006-2012 |
| International SAYE plans |
262,615 |
231p-439p |
2006-2010 |
| Executive schemes |
1,416,590 |
257.5p-653p |
2006-2015 |
| |
1,950,167 |
|
|
On 2 June 2005, awards over an aggregate of 557,090 shares in the Company were made to 67 senior Group executives under the Company’s Long Term Incentive Plan. The total number of shares outstanding at 31 December 2005 under the Company’s Long Term Incentive Plan was 914,279 (2004: 476,283). The terms of the awards and the related performance conditions are described in the Remuneration Report.
On 30 June 2005, awards over an aggregate of 93,441 shares in the Company were made to nine senior Group executives under the Company’s Deferred Bonus Plan. The total number of shares outstanding at 31 December 2005 under the Company’s Deferred Bonus Plan was 140,161 (2004: 47,295). The terms of the awards and the related performance conditions are described in the Remuneration Report.
Information correct at 04/05/2006